·   Log in

Teva seeks to market generic version of Nuvigil

Written by: David Castillo on October 24th, 2009
Bookmark and Share
Nuvigil_50_150_250_57890_57891
Teva seeks to market generic version of Nuvigil   | read this item

Last Wednesday, Cephalon Inc. notified Teva Pharmaceuticals has filed an application to the United States (US) Food and Drug Administration to seek approval to market Nuvigil.

Nuvigil is a sleep disorder drug, which can improve obstructive sleep apnea. It is actually an improved version of Cephalon’s Provigil, another sleep disorder drug.

In its application, Teva Pharmaceuticals says that Cephalon patents for Nuvigil are “invalid invalid, unenforceable and/or will not be infringed by the product described in Teva’s submission.”

According to reports, the company is now reviewing the notice letter.

Source: Philadelphia Business Journal

Nuvigil_50_150_250_57890_57891


  1. [...] Read the original here: Teva seeks to market generic version of Nuvigil | Shift Work … [...]

You must be logged in to post a comment.